The information contained within
this announcement is deemed to constitute inside information as
stipulated under the retained EU law version of the Market Abuse
Regulation (EU) No. 596/2014 (the "UK MAR") which is part
of UK law by virtue of the European
Union (Withdrawal) Act 2018. The information is disclosed in
accordance with the Company's obligations under Article 17 of
the UK MAR. Upon the publication of this announcement,
this inside information is now considered to be in the public
domain.
20 December 2024
Eden Research
plc
("Eden"
or "the Company")
Regulatory approval for
Novellus+ in Mexico
Eden Research plc (AIM: EDEN), a
leader in sustainable biopesticide and biocontrol products, is
pleased to announce that it has received regulatory approval in
Mexico for Novellus®+, a new, enhanced version of its flagship
fungicide, MevaloneÒ. The product's regulatory approval applies to its use against
botrytis on a range of horticultural crops, comprising grapes,
tomatoes, peppers, potatoes, strawberries, blueberries,
raspberries, gooseberries, eggplant, okra, as well as several other
high value fruit and vegetables.
Novellus+ will be exclusively
distributed and sold by Sipcam Oxon's Mexican subsidiary, Advan
Mexico SA de CV ("Advan"). Advan is one of Mexico's largest
agrochemical input providers and supplies an extensively network of
farmers across the nation.
This latest authorisation is Eden's
second authorised product in Mexico, having previously obtained
regulatory approval for its bionematicide, Cedroz™, in 2019.
The addition of Novellus+ is expected to meaningfully
contribute to the Company's revenues in the coming
seasons.
The Mexican agricultural sector is
recognised for being a diverse market with its wide variety of
crops in multiple categories. Mexico ranks with the world's largest
15 economies and is home to a number of leading international
organisations, accompanied by world class universities and research
centres specialised in crop science. A large share of Mexico's
agricultural production is exported, with the US as its largest
export market. Such exports demand high quality production
standards and a strong pressure for residue-free harvests from the
food chain to meet strict cross-border regulations. Mexican exports
of berries to the US represented approximately $3.5 billion in
2022, with tomatoes and peppers constituting approximately $2.5
billion and $1.6 billion1 respectively.
Sean
Smith, Chief Executive Officer of Eden Research plc,
commented:
"Given the significance of Mexico's
agricultural exports, the approval for Novellus+ in Mexico marks an
important milestone for the Company as we continue to grow our
product sales across North America. Critically, this latest
approval includes an extensive range of crops which means that we
are able to take advantage of the diverse nature of Mexico's
agricultural market as well as its standing as one of the world's
largest crop producing nations.
This is also an exciting development
as Novellus+ represents an evolution of Mevalone, allowing improved
rates in the field, high levels of efficacy and a broader list of
targets, all contributing to a larger addressable market in select
territories. Registration efforts are also well underway in several
additional countries, and we look forward to providing further
updates on the growth of Novellus+ within our portfolio.
We believe that the sustainability
and efficacy of Novellus+ will stand our product apart in a growing
market, particularly as local regulations increasingly demand
strict control of pesticide residues on fruit and vegetables in
order to meet consumer expectations and international
standards."
Giulio Testa, Product Manager Biorationals, Sipcam Oxon,
commented:
"Sipcam Oxon is excited about the
new registration of Novellus+ in Mexico. This milestone further
strengthens the product development pipeline in key markets where
Sipcam Oxon operates through its affiliates. With its high-value
crops and vegetables, primarily grown for export, Mexico offers
significant market potential for botanical products like Novellus+.
The successful development of Novellus+ highlights the fruitful
collaboration between Eden and Sipcam, combining their expertise to
create an enhanced formulation that delivers consistent efficacy
and versatility."
1 SOURCE:
https://www.ers.usda.gov/topics/international-markets-u-s-trade/countries-regions/usmca-canada-mexico/mexico-trade-fdi/
- ENDS
-
For further information
contact:
Eden
Research plc
|
www.edenresearch.com
|
Sean Smith
Alex Abrey
|
01285 359
555
|
|
|
Cavendish Capital Markets Limited (Nominated advisor and
broker)
|
|
Giles Balleny / George
Lawson (Corporate Finance)
Charlie Combe (Broking)
Michael Johnson (Sales)
|
020 7397
8900
|
|
|
Hawthorn Advisors (Financial PR)
|
|
Victoria Ainsworth
|
eden@hawthornadvisors.com
|
Notes to Editors:
Eden Research is the
only UK-listed company focused on biopesticides for
sustainable agriculture. It develops and supplies innovative
biopesticide products and natural microencapsulation technologies
to the global crop protection, animal health and consumer products
industries.
Eden's products are formulated with
terpene active ingredients, based on natural plant defence
metabolites. To date, they have been primarily used on high-value
fruits and vegetables, improving crop yields and marketability,
with equal or better performance when compared with conventional
pesticides. Eden has three products currently on the
market:
Based on plant-derived active
ingredients, Mevalone® is a foliar biofungicide which
targets fungal diseases, such as Botyrtis cinerea, powdery mildew,
and downy mildew, affecting high-value fruit and vegetable
crops. It is a useful tool in crop defence programmes
and is aligned with the requirements of integrated pest management
programmes. It is approved for sale in a number of key
countries whilst Eden and its partners pursue regulatory clearance
in new territories thereby growing Eden's addressable market
globally.
Cedroz™ is a
bionematicide that targets free living nematodes which are
parasitic worms that affect a wide range of high-value fruit and
vegetable crops globally. Cedroz is registered for sale on two
continents and Eden's commercial collaborator, Eastman Chemical, is
pursuing registration and commercialisation of this important new
product in numerous countries globally.
Eden's seed treatment
product, EcovelexÔ was developed to safely tackle crop destruction caused
by birds - a major cause of losses in maize and other
crops. Ecovelex works by creating an unpleasant taste or odour
that repels birds, leaving the seeds safely intact and the birds
unaffected and free to find alternative food sources. The
product is based on Eden's plant-derived chemistry, registered in
the EU, US and elsewhere, and formulated using Eden's Sustaine®
microencapsulation system.
Eden's Sustaine® encapsulation
technology is used to harness the biocidal efficacy of naturally
occurring chemicals produced by plants (terpenes) and can also be
used with both natural and synthetic compounds to enhance their
performance and ease-of-use. Sustaine microcapsules are
naturally-derived, plastic-free, biodegradable micro-spheres
derived from yeast. It is one of the only viable, proven and
immediately registerable solutions to the microplastics problem in
formulations requiring encapsulation.
Eden was admitted to trading on AIM
on 11 May 2012 and trades under the symbol EDEN. It was
awarded the London Stock Exchange Green Economy Mark in January
2021, which the Company still holds to date. The Green Economy Mark
recognises London-listed companies that derive over 50% of
their total annual revenue from products and services that
contribute to the global green economy. Eden derives 100% of its
total annual revenues from sustainable products and
services.
For more information about Eden,
please visit: www.edenresearch.com.